x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2017 > 4th ESO Lung Cancer Observatory: innovation and care in the next 12 months
Print

4th ESO Lung Cancer Observatory: innovation and care in the next 12 months

07.05.2017

Geneva, Switzerland

ADVANCED COURSES & SEMINARS

Lung cancer

Description

Chairs: M.S. Aapro, CH - E. Felip, ES



The European School of Oncology is pleased to announce the 4th edition of "ESO Lung Cancer Observatory: innovation and care in the next 12 months", which will be held during the ELCC 2017 European Lung Cancer Conference on May 7 in Geneva, chaired by Dr. M.S Aapro and Dr. E. Felip, ES. The scope of the session is to provide the participants with a take home message on what they can expect to happen in the prostate cancer field in the next 12 months.


The Observatory will be held during the



General information

ESO SECRETARIAT
Daniela Mengato
European School of Oncology
Via Turati 29
20121, Milan, Italy
dmengato@eso.net


VENUE
Palexpo
30 Route François-Peyrot
1218 Le Grand-Saconnex
Geneva
Switzerland


ATTENDANCE
Attendance is granted to all participants registered to the ELCC 2017 European Lung Cancer Conference.




 

 

Faculty list


PANELLISTS
M.S. Aapro, Clinique de Genolier, Geneva, CH
C. Adams, Union for International Cancer Control (UICC), Geneva, CH
H. de Koning, Erasmus University Rotterdam, NL
E. Felip, Vall d’Hebron University Hospital, Barcelona, ES
F. Johansson, Swedish Lung Cancer Association “Stodet”, Stockholm, SE
K. Kerr, Abardeen Royal Infirmary, Foresterhill, Abardeen, UK
F. Mornex, Centre Hospitalier Lyon Sud, FR
U. Pastorino, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, IT

Programme


PROGRAMME

16:45 - 18:15 - Palexpo, Room W
Prevention: are we progressing in anti-tobacco campaigns in the world?
C. Adams, CH
Screening: where will it be in 2018?
H. de Koning, NL
Surgery or radiation: when is it a choice?
U. Pastorino, IT
Radiation oncology: will guidelines change?
F. Mornex, FR
What to ask your pathologist today and in 2018?
K. Kerr, UK
Developments in medical oncology: what practice changing studies will mature in 2018?
E. Felip, ES
The patient’s perspective
F. Johansson, SE

Follow us